Results 101 to 110 of about 47,532 (242)
Bupropion SR for the treatment of postpartum depression: a pilot study [PDF]
, 2005 Ruta Nonacs +5 more
openalex +1 more source
Journal of Sleep Research, Volume 34, Issue 2, April 2025.Summary Parasomnias and sleep‐related movement disorders (SRMD) are major causes of sleep disorders and may be drug induced. The objective of this study was to conduct a systematic review of the literature to examine the association between drug use and the occurrence of parasomnias and SRMD.
Sylvain Dumont +5 more
wiley +1 more source
Helping Smokers Quit: State Cessation Coverage [PDF]
, 2008 Analyzes state health insurance coverage for treatments to quit smoking and how coverage through state Medicaid, state employee health plans, private insurance, and "quitlines" saves states healthcare costs.
core
Impact of Cannabis Smoking on Multiple Sleep Latency Test Outcomes
Journal of Sleep Research, EarlyView.ABSTRACT Our purpose was to evaluate how cannabis smoking influenced multiple sleep latency test (MSLT) outcomes. This was a retrospective study of all adults that had undergone a MSLT at St. Michael's Hospital (Toronto, Ontario, Canada) from 1 January 2008 until 31 December 2018.
Kosta Tzanis +3 more
wiley +1 more source
Journal of Sleep Research, EarlyView.ABSTRACT The present study aims at verifying whether the conditional probability of observing a poor night after one, two, or three consecutive poor nights is associated with sleep depth or sleep self‐estimation. Online sleep diaries were collected for 21 consecutive nights from 30 adults with insomnia.
D. Laroche, A. Vallières, C. H. Bastien
wiley +1 more source
Smoking cessation and tobacco prevention in Indigenous populations [PDF]
This article systematically reviews 91 smoking cessation and tobacco prevention studies tailored for Indigenous populations around the world, with a particular focus on Aboriginal and Torres Strait Islander populations in Australia. We identified several
Adrian Esterman +9 more
core +1 more source
Neurogastroenterology &Motility, EarlyView.DGBI symptoms are common in obesity and have the potential to exacerbate negative health outcomes. In general, the prevalence of DGBI symptoms decreases after obesity treatment, but patients can also shift from one GI symptom profile to another. ABSTRACT Background & Aims Disorders of gut‐brain interaction (DGBI) in obesity could impair health outcomes.
Esther Colomier +11 more
wiley +1 more source
Risk Factors for Cardiovascular and Metabolic Disease: Integrating Traditional and Novel Paradigms
iNew Medicine, Volume 1, Issue 1, December 2025.ABSTRACT Cardiovascular and metabolic diseases (CVMD), encompassing atherosclerotic cardiovascular disease (ASCVD), heart failure, obesity, type 2 diabetes mellitus (T2DM), and metabolic dysfunction‐associated steatotic liver disease (MASLD), remain the leading global cause of morbidity and mortality.
Zhihua Wang +3 more
wiley +1 more source
Tobacco Cessation Treatments Among Young Adult Smokers [PDF]
, 2007 Summarizes a study of differences between younger and older adult smokers in their motivations and attempts to quit and their use of smoking cessation treatments.
Amy Sporer +5 more
core